Page last updated: 2024-08-26

1-(1-naphthyl)ethylamine and Benign Neoplasms

1-(1-naphthyl)ethylamine has been researched along with Benign Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Albert, J; Badía, J; Baldomà, L; Bosque, R; Calvis, C; Cascante, M; Crespo, M; Font-Bardia, M; González, A; Granell, J; Jayaraman, A; López, C; Martín, R; Messeguer, R; Quirante, J	1

Other Studies

1 other study(ies) available for 1-(1-naphthyl)ethylamine and Benign Neoplasms

Article	Year
Neutral and ionic platinum compounds containing a cyclometallated chiral primary amine: synthesis, antitumor activity, DNA interaction and topoisomerase I-cathepsin B inhibition. Dalton transactions (Cambridge, England : 2003), 2015, Aug-14, Volume: 44, Issue:30 Topics: Antineoplastic Agents; Apoptosis; Cathepsin B; Cations; Cell Cycle Checkpoints; Cell Line, Tumor; DNA; Ethylamines; Humans; Models, Molecular; Naphthalenes; Neoplasms; Organoplatinum Compounds; Topoisomerase I Inhibitors	2015

Article

Year

Neutral and ionic platinum compounds containing a cyclometallated chiral primary amine: synthesis, antitumor activity, DNA interaction and topoisomerase I-cathepsin B inhibition.

Dalton transactions (Cambridge, England : 2003), 2015, Aug-14, Volume: 44, Issue:30

Topics: Antineoplastic Agents; Apoptosis; Cathepsin B; Cations; Cell Cycle Checkpoints; Cell Line, Tumor; DNA; Ethylamines; Humans; Models, Molecular; Naphthalenes; Neoplasms; Organoplatinum Compounds; Topoisomerase I Inhibitors

2015